Press Releases
ArteraAI Announces Positive Results Around Its Multimodal Artificial Intelligence (MMAI) Prognostic Biomarker
Validated across six phase III randomized trials, the biomarker demonstrated the ability to help enable personalized, shared [...]
Press Releases
Our science was presented at the 2023 ASCO Genitourinary Cancers Symposium in San Francisco from February 16-18.
Patient-Level Data Meta-Analysis of a Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate C [...]